Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Effect of laminin environments and tumor factors on the biology of myeloid dendritic cells.

Phillippi B, Singh M, Loftus T, Smith H, Muccioli M, Wright J, Pate M, Benencia F.

Immunobiology. 2019 Nov 10. pii: S0171-2985(19)30176-7. doi: 10.1016/j.imbio.2019.10.003. [Epub ahead of print]

PMID:
31753553
2.

Inflammatory processes in obesity: focus on endothelial dysfunction and the role of adipokines as inflammatory mediators.

Singh M, Benencia F.

Int Rev Immunol. 2019;38(4):157-171. doi: 10.1080/08830185.2019.1638921. Epub 2019 Jul 9.

PMID:
31286783
3.

Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors.

Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ Jr, Gimotty PA, Facciabene A, Jackson DG, Weber JS, Rodig SJ, Hodi SF, Kandalaft LE, Irving M, Zhang L, Foukas P, Rusakiewicz S, Delorenzi M, Coukos G.

Cancer Cell. 2019 Jun 10;35(6):885-900.e10. doi: 10.1016/j.ccell.2019.05.004.

PMID:
31185212
4.

Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues.

Muccioli M, Nandigam H, Loftus T, Singh M, Venkatesh A, Wright J, Pate M, McCall K, Benencia F.

Oncotarget. 2018 Nov 30;9(94):36666-36683. doi: 10.18632/oncotarget.26378. eCollection 2018 Nov 30.

5.

Please stand by: how oncolytic viruses impact bystander cells.

Sprague L, Braidwood L, Conner J, Cassady KA, Benencia F, Cripe TP.

Future Virol. 2018 Sep;13(9):671-680. doi: 10.2217/fvl-2018-0068. Epub 2018 Aug 8. Review.

6.

Regulation of inflammatory factors by double-stranded RNA receptors in breast cancer cells.

Venkatesh A, Nandigam H, Muccioli M, Singh M, Loftus T, Lewis D, Pate M, Benencia F.

Immunobiology. 2018 Jun - Jul;223(6-7):466-476. doi: 10.1016/j.imbio.2017.11.005. Epub 2017 Nov 22.

PMID:
29331323
7.

Stress-Induced Parasympathetic Control and Its Association With Inflammatory Reactivity.

Woody A, Figueroa WS, Benencia F, Zoccola PM.

Psychosom Med. 2017 Apr;79(3):306-310. doi: 10.1097/PSY.0000000000000426.

PMID:
28002383
8.

Minireview: Regulatory T Cells and Ovarian Cancer.

Singh M, Loftus T, Webb E, Benencia F.

Immunol Invest. 2016 Nov;45(8):712-720. Epub 2016 Jul 15. Review.

PMID:
27420920
9.

Designing a broad-spectrum integrative approach for cancer prevention and treatment.

Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin ARMR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, Bishayee A, Blain SW, Block PB, Boosani CS, Carey TE, Carnero A, Carotenuto M, Casey SC, Chakrabarti M, Chaturvedi R, Chen GZ, Chen H, Chen S, Chen YC, Choi BK, Ciriolo MR, Coley HM, Collins AR, Connell M, Crawford S, Curran CS, Dabrosin C, Damia G, Dasgupta S, DeBerardinis RJ, Decker WK, Dhawan P, Diehl AME, Dong JT, Dou QP, Drew JE, Elkord E, El-Rayes B, Feitelson MA, Felsher DW, Ferguson LR, Fimognari C, Firestone GL, Frezza C, Fujii H, Fuster MM, Generali D, Georgakilas AG, Gieseler F, Gilbertson M, Green MF, Grue B, Guha G, Halicka D, Helferich WG, Heneberg P, Hentosh P, Hirschey MD, Hofseth LJ, Holcombe RF, Honoki K, Hsu HY, Huang GS, Jensen LD, Jiang WG, Jones LW, Karpowicz PA, Keith WN, Kerkar SP, Khan GN, Khatami M, Ko YH, Kucuk O, Kulathinal RJ, Kumar NB, Kwon BS, Le A, Lea MA, Lee HY, Lichtor T, Lin LT, Locasale JW, Lokeshwar BL, Longo VD, Lyssiotis CA, MacKenzie KL, Malhotra M, Marino M, Martinez-Chantar ML, Matheu A, Maxwell C, McDonnell E, Meeker AK, Mehrmohamadi M, Mehta K, Michelotti GA, Mohammad RM, Mohammed SI, Morre DJ, Muralidhar V, Muqbil I, Murphy MP, Nagaraju GP, Nahta R, Niccolai E, Nowsheen S, Panis C, Pantano F, Parslow VR, Pawelec G, Pedersen PL, Poore B, Poudyal D, Prakash S, Prince M, Raffaghello L, Rathmell JC, Rathmell WK, Ray SK, Reichrath J, Rezazadeh S, Ribatti D, Ricciardiello L, Robey RB, Rodier F, Rupasinghe HPV, Russo GL, Ryan EP, Samadi AK, Sanchez-Garcia I, Sanders AJ, Santini D, Sarkar M, Sasada T, Saxena NK, Shackelford RE, Shantha Kumara HMC, Sharma D, Shin DM, Sidransky D, Siegelin MD, Signori E, Singh N, Sivanand S, Sliva D, Smythe C, Spagnuolo C, Stafforini DM, Stagg J, Subbarayan PR, Sundin T, Talib WH, Thompson SK, Tran PT, Ungefroren H, Vander Heiden MG, Venkateswaran V, Vinay DS, Vlachostergios PJ, Wang Z, Wellen KE, Whelan RL, Yang ES, Yang H, Yang X, Yaswen P, Yedjou C, Yin X, Zhu J, Zollo M.

Semin Cancer Biol. 2015 Dec;35 Suppl:S276-S304. doi: 10.1016/j.semcancer.2015.09.007. Review.

10.

Trait reflection predicts interleukin-6 response to a social-evaluative stressor.

Woody A, Figueroa WS, Benencia F, Zoccola PM.

Brain Behav Immun. 2016 Feb;52:27-31. doi: 10.1016/j.bbi.2015.10.011. Epub 2015 Oct 23.

PMID:
26526647
11.

Immunotherapy for ovarian cancer: what are the targets of the future?

Adams SF, Benencia F.

Future Oncol. 2015;11(9):1293-6. doi: 10.2217/fon.15.44. No abstract available.

12.

GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells.

Olarescu NC, Berryman DE, Householder LA, Lubbers ER, List EO, Benencia F, Kopchick JJ, Bollerslev J.

J Endocrinol. 2015 Jul;226(1):13-23. doi: 10.1530/JOE-15-0012. Epub 2015 May 5.

13.

Cancer prevention and therapy through the modulation of the tumor microenvironment.

Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW.

Semin Cancer Biol. 2015 Dec;35 Suppl:S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Review.

14.

Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations.

Benencia F, Harshman S, Duran-Ortiz S, Lubbers ER, List EO, Householder L, Al-Naeeli M, Liang X, Welch L, Kopchick JJ, Berryman DE.

Endocrinology. 2015 May;156(5):1794-803. doi: 10.1210/en.2014-1794. Epub 2014 Dec 18.

15.

Toll-like receptor 3 is critical for coxsackievirus B4-induced type 1 diabetes in female NOD mice.

McCall KD, Thuma JR, Courreges MC, Benencia F, James CB, Malgor R, Kantake N, Mudd W, Denlinger N, Nolan B, Wen L, Schwartz FL.

Endocrinology. 2015 Feb;156(2):453-61. doi: 10.1210/en.2013-2006. Epub 2014 Nov 25.

16.

CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions.

Shirure VS, Liu T, Delgadillo LF, Cuckler CM, Tees DF, Benencia F, Goetz DJ, Burdick MM.

Am J Physiol Cell Physiol. 2015 Jan 1;308(1):C68-78. doi: 10.1152/ajpcell.00094.2014. Epub 2014 Oct 22.

17.

Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies.

Muccioli M, Benencia F.

Front Immunol. 2014 Jul 22;5:341. doi: 10.3389/fimmu.2014.00341. eCollection 2014. Review.

18.

Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors.

Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G.

Nat Med. 2014 Jun;20(6):607-15. doi: 10.1038/nm.3541. Epub 2014 May 4.

19.

Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies.

Benencia F, Muccioli M, Alnaeeli M.

Front Oncol. 2014 Apr 7;4:72. doi: 10.3389/fonc.2014.00072. eCollection 2014. Review.

20.

Antigen-specific mRNA transfection of autologous dendritic cells.

Benencia F.

Methods Mol Biol. 2014;1139:77-86. doi: 10.1007/978-1-4939-0345-0_8.

PMID:
24619672
21.

Osteopathic manipulative therapy induces early plasma cytokine release and mobilization of a population of blood dendritic cells.

Walkowski S, Singh M, Puertas J, Pate M, Goodrum K, Benencia F.

PLoS One. 2014 Mar 10;9(3):e90132. doi: 10.1371/journal.pone.0090132. eCollection 2014.

22.

Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments.

Sprague L, Muccioli M, Pate M, Singh M, Xiong C, Ostermann A, Niese B, Li Y, Li Y, Courreges MC, Benencia F.

Exp Cell Res. 2014 Apr 15;323(1):7-27. doi: 10.1016/j.yexcr.2014.01.031. Epub 2014 Feb 22.

PMID:
24569142
23.

Differential effects of poststressor rumination and distraction on cortisol and C-reactive protein.

Zoccola PM, Figueroa WS, Rabideau EM, Woody A, Benencia F.

Health Psychol. 2014 Dec;33(12):1606-9. doi: 10.1037/hea0000019. Epub 2014 Jan 27.

PMID:
24467256
24.

A role for the chemokine receptor CCR6 in mammalian sperm motility and chemotaxis.

Caballero-Campo P, Buffone MG, Benencia F, Conejo-García JR, Rinaudo PF, Gerton GL.

J Cell Physiol. 2014 Jan;229(1):68-78. doi: 10.1002/jcp.24418.

25.

Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice.

McCall KD, Schmerr MJ, Thuma JR, James CB, Courreges MC, Benencia F, Malgor R, Schwartz FL.

Molecules. 2013 Mar 27;18(4):3841-58. doi: 10.3390/molecules18043841.

26.

Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?

Burdick MM, Henson KA, Delgadillo LF, Choi YE, Goetz DJ, Tees DF, Benencia F.

Front Oncol. 2012 Aug 20;2:103. doi: 10.3389/fonc.2012.00103. eCollection 2012.

27.

Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma.

Muccioli M, Longstaff C, Benencia F.

Immunotherapy. 2012 May;4(5):477-81. doi: 10.2217/imt.12.39.

28.

Adhesion to substrates induces dendritic cell endothelization and decreases immunological response.

Osterbur J, Sprague L, Muccioli M, Pate M, Mansfield K, McGinty J, Li Y, Li Y, Shirure V, Courreges MC, Benencia F.

Immunobiology. 2013 Jan;218(1):64-75. doi: 10.1016/j.imbio.2012.02.003. Epub 2012 Feb 27.

29.

Toll-like receptors as novel therapeutic targets for ovarian cancer.

Muccioli M, Sprague L, Nandigam H, Pate M, Benencia F.

ISRN Oncol. 2012;2012:642141. doi: 10.5402/2012/642141. Epub 2012 Mar 4.

30.

Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination.

Benencia F, Sprague L, McGinty J, Pate M, Muccioli M.

J Biomed Biotechnol. 2012;2012:425476. doi: 10.1155/2012/425476. Epub 2012 Mar 15. Review.

31.

Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies.

Muccioli M, Pate M, Omosebi O, Benencia F.

J Vis Exp. 2011 Jun 2;(52). pii: 2785. doi: 10.3791/2785.

32.

The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells.

Sprague L, Muccioli M, Pate M, Meles E, McGinty J, Nandigam H, Venkatesh AK, Gu MY, Mansfield K, Rutowski A, Omosebi O, Courreges MC, Benencia F.

BMC Immunol. 2011 Jun 6;12:35. doi: 10.1186/1471-2172-12-35.

33.

Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy.

Alagkiozidis I, Facciabene A, Tsiatas M, Carpenito C, Benencia F, Adams S, Jonak Z, June CH, Powell DJ Jr, Coukos G.

J Transl Med. 2011 May 25;9:77. doi: 10.1186/1479-5876-9-77.

34.

Whole tumor antigen vaccines.

Chiang CL, Benencia F, Coukos G.

Semin Immunol. 2010 Jun;22(3):132-43. doi: 10.1016/j.smim.2010.02.004. Epub 2010 Mar 30. Review.

35.

Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18.

Alagkiozidis I, Facciabene A, Carpenito C, Benencia F, Jonak Z, Adams S, Carroll RG, Gimotty PA, Hammond R, Danet-Desnoyers GÄ, June CH, Powell DJ Jr, Coukos G.

J Transl Med. 2009 Dec 10;7:104. doi: 10.1186/1479-5876-7-104.

36.

Aminoguanidine administered during the induction of oral tolerance alters the systemic response of the tolerised rats.

Franco LG, Feledi CA, Massouh EJ, Benencia F.

Cell Immunol. 2010;261(1):42-50. doi: 10.1016/j.cellimm.2009.10.010. Epub 2009 Oct 25.

PMID:
19931043
37.

In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes.

Christian NA, Benencia F, Milone MC, Li G, Frail PR, Therien MJ, Coukos G, Hammer DA.

Mol Imaging Biol. 2009 May-Jun;11(3):167-77. doi: 10.1007/s11307-008-0184-x. Epub 2009 Feb 5.

38.

Modulation of the antitumor immune response by complement.

Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, Coukos G, Lambris JD.

Nat Immunol. 2008 Nov;9(11):1225-35. doi: 10.1038/ni.1655. Epub 2008 Sep 28.

39.

Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity.

Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Buckanovich RJ, Benencia F, Stan RV, Keler T, Sarobe P, Sentman CL, Conejo-Garcia JR.

Cancer Res. 2008 Sep 15;68(18):7684-91. doi: 10.1158/0008-5472.CAN-08-1167. Epub 2008 Sep 3.

40.

Biological therapy with oncolytic herpesvirus.

Benencia F, Coukos G.

Adv Exp Med Biol. 2008;622:221-33. doi: 10.1007/978-0-387-68969-2_18. Review. No abstract available.

PMID:
18546631
41.

Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation.

Benencia F, Courrèges MC, Fraser NW, Coukos G.

Cancer Biol Ther. 2008 Aug;7(8):1194-205. Epub 2008 Aug 1.

PMID:
18458533
42.

Wnt5a is expressed in murine and human atherosclerotic lesions.

Christman MA 2nd, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, Benencia F, Silver MJ, Kohn LD, Malgor R.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2864-70. doi: 10.1152/ajpheart.00982.2007. Epub 2008 May 2.

43.

Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells.

Benencia F, Courrèges MC, Coukos G.

J Transl Med. 2008 Apr 29;6:21. doi: 10.1186/1479-5876-6-21.

44.

Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy.

Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G.

Nat Med. 2008 Jan;14(1):28-36. Epub 2008 Jan 6.

PMID:
18157142
45.

Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer.

Coukos G, Conejo-Garcia JR, Buckanovich R, Benencia F.

Adv Exp Med Biol. 2007;590:185-93. Review. No abstract available.

PMID:
17191386
46.

Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity.

Benencia F, Courrèges MC, Conejo-García JR, Mohammed-Hadley A, Coukos G.

Cancer Biol Ther. 2006 Jul;5(7):867-74. Epub 2006 Jul 18.

PMID:
16861891
47.

Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment.

Buckanovich RJ, Sasaroli D, O'brien-Jenkins A, Botbyl J, Conejo-Garcia JR, Benencia F, Liotta LA, Gimotty PA, Coukos G.

Cancer Biol Ther. 2006 Jun;5(6):635-42. Epub 2006 Jun 9.

PMID:
16627987
48.

Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines.

Courrèges MC, Benencia F, Conejo-García JR, Zhang L, Coukos G.

Cancer Gene Ther. 2006 Feb;13(2):182-93.

PMID:
16138121
49.

Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma.

Benencia F, Courreges MC, Conejo-García JR, Buckanovich RJ, Zhang L, Carroll RH, Morgan MA, Coukos G.

Hum Gene Ther. 2005 Jun;16(6):765-78.

PMID:
15960607
50.

HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer.

Benencia F, Courrèges MC, Conejo-García JR, Mohamed-Hadley A, Zhang L, Buckanovich RJ, Carroll R, Fraser N, Coukos G.

Mol Ther. 2005 Nov;12(5):789-802. Epub 2005 May 31.

Supplemental Content

Loading ...
Support Center